×
About 7,855 results

ALLMedicine™ Bronchitis Center

Research & Reviews  1,814 results

Asthma
http://emedicine.medscape.com/article/296301-overview

May 11th, 2022 - Practice Essentials Asthma is a common chronic disease worldwide and affects approximately 26 million persons in the United States. It is the most common chronic disease in childhood, affecting an estimated 7 million children. The pathophysiology ...

Genetic variation of six specific SNPs of chronic obstructive pulmonary disease among C...
https://doi.org/10.1016/j.pulmoe.2022.02.004
Pulmonology Jing J, Xu D et. al.

May 3rd, 2022 - Chronic obstructive pulmonary disease (COPD) is a chronic bronchitis (or) emphysema with a high disability and fatality rate. This study aimed to explore the correlation between the six selected single nucleotide polymorphisms (SNPs) and the risk ...

Age-specific associations of early daycare, older siblings, severe airway infection, an...
https://doi.org/10.1111/pai.13771
Pediatric Allergy and Immunology : Official Publication O... Nagasaki T, Tabuchi T et. al.

Apr 27th, 2022 - The effects of infection and developmental adaptations in infancy on the prevalence of subsequent atopy-related diseases at different ages during childhood are not fully determined. This study aims to examine the similarities and differences in th...

Large integrated safety analysis reinforces known safety profile of ixekizumab in PsA
https://www.mdedge.com/dermatology/article/254006/psoriatic-arthritis/large-integrated-safety-analysis-reinforces-known

Apr 25th, 2022 - Key clinical point: Ixekizumab demonstrated an overall consistent safety and tolerability profile with no unexpected/new adverse events (AE) in patients with psoriatic arthritis (PsA) and up to 3 years of exposure to ixekizumab. Major finding: Tre.

Woodsmoke Particulate + Hypertonic Saline
https://clinicaltrials.gov/ct2/show/NCT03851406

Apr 25th, 2022 - Military deployment is associated with exposure to novel particulate matter (PM), such as from burn pits, aeroallergens, and increased cigarette consumption. War fighters exposed to these inhalational exposures exhibit immediate and chronic respir...

see more →

Guidelines  6 results

ACR Appropriateness Criteria® Chronic Cough.
https://doi.org/10.1016/j.jacr.2021.08.007
Journal of the American College of Radiology : JACR; , Kuzniewski CT et. al.

Nov 20th, 2021 - Chronic cough is defined by a duration lasting at least 8 weeks. The most common causes of chronic cough include smoking-related lung disease, upper airway cough syndrome, asthma, gastroesophageal reflux disease, and nonasthmatic eosinophilic bron...

Appropriate Use of Short-Course Antibiotics in Common Infections: Best Practice Advice ...
https://doi.org/10.7326/M20-7355
Annals of Internal Medicine; Lee RA, Centor RM et. al.

Apr 6th, 2021 - Antimicrobial overuse is a major health care issue that contributes to antibiotic resistance. Such overuse includes unnecessarily long durations of antibiotic therapy in patients with common bacterial infections, such as acute bronchitis with chro...

Chronic Cough Due to Stable Chronic Bronchitis: CHEST Expert Panel Report.
https://doi.org/10.1016/j.chest.2020.02.015
Chest Malesker MA, Callahan-Lyon P et. al.

Feb 28th, 2020 - Chronic cough due to chronic bronchitis (CB) causes significant impairment in quality of life, and effective treatment strategies are needed. We conducted a systematic review on the management of chronic cough due to CB to update the recommendatio...

Acute Cough Due to Acute Bronchitis in Immunocompetent Adult Outpatients: CHEST Expert ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8173775
Chest Smith MP, Lown M et. al.

Feb 25th, 2020 - Evidence for the diagnosis and management of cough due to acute bronchitis in immunocompetent adult outpatients was reviewed as an update to the 2006 "Chronic Cough Due to Acute Bronchitis: American College of Chest Physicians (ACCP) Evidence-Base...

Managing Chronic Cough Due to Asthma and NAEB in Adults and Adolescents: CHEST Guidelin...
https://doi.org/10.1016/j.chest.2019.12.021
Chest Côté A, Russell RJ et. al.

Jan 24th, 2020 - Asthma and non-asthmatic eosinophilic bronchitis (NAEB) are among the commonest causes of chronic cough in adults. We sought to determine the role of non-invasive measurements of airway inflammation, including induced sputum and fractional exhaled...

see more →

Drugs  777 results see all →

Clinicaltrials.gov  111 results

Woodsmoke Particulate + Hypertonic Saline
https://clinicaltrials.gov/ct2/show/NCT03851406

Apr 25th, 2022 - Military deployment is associated with exposure to novel particulate matter (PM), such as from burn pits, aeroallergens, and increased cigarette consumption. War fighters exposed to these inhalational exposures exhibit immediate and chronic respir...

DNA Methylation Analysis in Acute Coronary Syndrome and Atrial Fibrillation: DIANA Clinical Trial
https://clinicaltrials.gov/ct2/show/NCT04371809

Apr 8th, 2022 - Study population will include 20 healthy controls admitted to electrocardiographic control without further cardiological, electrocardiographic and clinical evidence of cardiac pathologies, 20 patients with ACS, and 40 patients with ACS affected or...

Identifying Early Chronic Obstructive Pulmonary Disease (COPD) Using Health Administrative Data
https://clinicaltrials.gov/ct2/show/NCT04966637

Apr 7th, 2022 - Study Objectives Identifying a cohort of individuals with a new onset of COPD in the between April 1, 2016 and March 31, 2019. To determine factors associated with a new diagnosis of COPD through using traditional mixed-model regression. To evalua...

A Study of Gamma Tocopherol-enriched Supplement on Lower Airway Responses to Inhaled Wood Smoke in Healthy Adults
https://clinicaltrials.gov/ct2/show/NCT03444298

Mar 31st, 2022 - Particulate matter (PM) is a leading cause of respiratory tract and cardiovascular disease in the United States and world-wide. Wood smoke particles (WSP) derived from wildland and other fires account for a significant fraction of ambient air PM. ...

The Topic Trial - Study to Determine the Safety and Efficacy of Ivacaftor
https://clinicaltrials.gov/ct2/show/NCT03085485

Mar 25th, 2022 - Like CF, COPD is characterized by small airway mucus obstruction that is associated with accelerated loss of lung function and mortality. Preliminary data indicate that cigarette smoke exerts deleterious effects on airway epithelial function inclu...

see more →

News  409 results

Antibiotic Prescribing Practice Varies Widely in Canada
https://www.medscape.com/viewarticle/973789

May 11th, 2022 - Even before the COVID-19 pandemic, primary care doctors in Canada often prescribed antibiotics unnecessarily for respiratory tract infections such as the common cold, sinusitis, and acute bronchitis, according to new research. For some viral condi...

Large integrated safety analysis reinforces known safety profile of ixekizumab in PsA
https://www.mdedge.com/dermatology/article/254006/psoriatic-arthritis/large-integrated-safety-analysis-reinforces-known

Apr 25th, 2022 - Key clinical point: Ixekizumab demonstrated an overall consistent safety and tolerability profile with no unexpected/new adverse events (AE) in patients with psoriatic arthritis (PsA) and up to 3 years of exposure to ixekizumab. Major finding: Tre.

Black, Senior Patients More Likely to Get Unneeded Antibiotics
https://www.medscape.com/viewarticle/972492

Apr 20th, 2022 - Black and senior patients are more likely to be overprescribed antibiotics, according to a new study of 7 billion trips to healthcare centers — findings that doctors say warrant a further look into unequal prescription practices. Researchers at th...

FDA Approves Generic Symbicort for Asthma, COPD
https://www.medscape.com/viewarticle/970360

Mar 16th, 2022 - The US Food and Drug Administration (FDA) approved the first generic of Symbicort (budesonide and formoterol fumarate dihydrate) inhalation aerosol for the treatment of asthma in patients 6 years of age and older and for the maintenance treatment ...

Fast Five Quiz: Differential Diagnosis of Chronic Obstructive Pulmonary Disease (COPD)
https://reference.medscape.com/viewarticle/965154

Feb 4th, 2022 - Chronic obstructive pulmonary disease (COPD) is estimated to affect between 300 and 400 million people globally and is the third leading cause of death worldwide. The defining feature of COPD is irreversible airflow limitation during forced expira...

see more →

Patient Education  25 results see all →